These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 23187164)

  • 1. Topical application of bevacizumab as an adjunct to recurrent pterygium surgery.
    Ozgurhan EB; Agca A; Kara N; Yuksel K; Demircan A; Demirok A
    Cornea; 2013 Jun; 32(6):835-8. PubMed ID: 23187164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary results of subconjunctival bevacizumab in primary pterygium excision.
    Razeghinejad MR; Hosseini H; Ahmadi F; Rahat F; Eghbal H
    Ophthalmic Res; 2010; 43(3):134-8. PubMed ID: 19887878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, controlled trial of conjunctival autografting combined with subconjunctival bevacizumab for primary pterygium treatment: 1-year follow-up.
    Nava-Castañeda A; Olvera-Morales O; Ramos-Castellon C; Garnica-Hayashi L; Garfias Y
    Clin Exp Ophthalmol; 2014 Apr; 42(3):235-41. PubMed ID: 23777441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subconjunctival bevacizumab immediately after excision of primary pterygium: the first clinical trial.
    Shenasi A; Mousavi F; Shoa-Ahari S; Rahimi-Ardabili B; Fouladi RF
    Cornea; 2011 Nov; 30(11):1219-22. PubMed ID: 21955635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled prospective study to assess the role of subconjunctival bevacizumab in primary pterygium surgery in Indian patients.
    Singh P; Sarkar L; Sethi HS; Gupta VS
    Indian J Ophthalmol; 2015 Oct; 63(10):779-84. PubMed ID: 26655003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparative Study of Topical Mitomycin C, Cyclosporine, and Bevacizumab after Primary Pterygium Surgery.
    Hwang S; Choi S
    Korean J Ophthalmol; 2015 Dec; 29(6):375-81. PubMed ID: 26635453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative subconjunctival bevacizumab as an adjunctive treatment in primary pterygium: a preliminary report.
    Shahin MM; Elbendary AM; Elwan MM
    Ophthalmic Surg Lasers Imaging; 2012; 43(6):459-66. PubMed ID: 22882007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of subconjunctival ranibizumab in patients with primary pterygium undergoing pterygium surgery.
    Galor A; Yoo SH; Piccoli FV; Schmitt AJ; Chang V; Perez VL
    Am J Ophthalmol; 2010 Jun; 149(6):926-931.e2. PubMed ID: 20417925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of pterygium surgery with mitomycin C application using conjunctival autograft versus conjunctival-limbal autograft.
    Kheirkhah A; Hashemi H; Adelpour M; Nikdel M; Rajabi MB; Behrouz MJ
    Ophthalmology; 2012 Feb; 119(2):227-32. PubMed ID: 22153864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial of subconjunctival bevacizumab injection in impending recurrent pterygium: a pilot study.
    Lekhanont K; Patarakittam T; Thongphiew P; Suwan-apichon O; Hanutsaha P
    Cornea; 2012 Feb; 31(2):155-61. PubMed ID: 22081150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of recurrent pterygium with topical bevacizumab 0.05% eye drops: a randomized controlled trial.
    Kasetsuwan N; Reinprayoon U; Satitpitakul V
    Clin Ther; 2015 Oct; 37(10):2347-51. PubMed ID: 26409291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative conjunctival inflammation after pterygium surgery with amniotic membrane transplantation versus conjunctival autograft.
    Kheirkhah A; Nazari R; Nikdel M; Ghassemi H; Hashemi H; Behrouz MJ
    Am J Ophthalmol; 2011 Nov; 152(5):733-8. PubMed ID: 21742306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical bevacizumab eyedrops for limbal-conjunctival neovascularization in impending recurrent pterygium.
    Wu PC; Kuo HK; Tai MH; Shin SJ
    Cornea; 2009 Jan; 28(1):103-4. PubMed ID: 19092418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of topical bevacizumab for inhibiting growth of impending recurrent pterygium.
    Fallah MR; Khosravi K; Hashemian MN; Beheshtnezhad AH; Rajabi MT; Gohari M
    Curr Eye Res; 2010 Jan; 35(1):17-22. PubMed ID: 20021250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of three methods for the treatment of pterygium: amniotic membrane graft, conjunctival autograft and conjunctival autograft plus mitomycin C.
    Katircioğlu YA; Altiparmak UE; Duman S
    Orbit; 2007 Mar; 26(1):5-13. PubMed ID: 17510864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subconjunctival bevacizumab injection in the surgery of primary pterygium: comparison with intraoperative mitomycin-C.
    Kocabora SM; Fazil K; Ozsutcu M; Doyduk-Kocabora A; Gulkilik G
    Bull Soc Belge Ophtalmol; 2013; (322):7-12. PubMed ID: 24923076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pterygium by ligation and bevacizumab injection.
    Nakasato H; Uemoto R; Mizuki N
    Cornea; 2012 Nov; 31(11):1339-41. PubMed ID: 22710493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated bevacizumab injections versus mitomycin C in rotational conjunctival flap for prevention of pterygium recurrence.
    Ozsutcu M; Ayintap E; Akkan JC; Koytak A; Aras C
    Indian J Ophthalmol; 2014 Apr; 62(4):407-11. PubMed ID: 24178405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of recurrent pterygium with intraoperative mitomycin C and conjunctival autograft with fibrin glue.
    Shehadeh-Mashor R; Srinivasan S; Boimer C; Lee K; Tomkins O; Slomovic AR
    Am J Ophthalmol; 2011 Nov; 152(5):730-2. PubMed ID: 21742307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of different doses of subconjunctival bevacizumab on the recurrence rate of excised primary pterygium.
    Razeghinejad R; Banifatemi M; Hosseini H
    Bull Soc Belge Ophtalmol; 2013; (322):13-20. PubMed ID: 24923077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.